Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma
Clinical Immunology · 2026-12 · 288 · 110765
DOI: 10.1016/j.clim.2026.110765 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Immunology, 2026-12. Verfasst von Tareq Nayef AlRamadneh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: t…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 234 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) develops within a chronically inflamed and immunologically dysregulated hepatic microenvironment that contributes to therapeutic resistance and disease progression. Gasdermin-mediated pyroptosis has emerged as a context-dependent inflammatory cell-death program capable of reshaping antitumor immunity, stromal remodeling, and immune checkpoint responsiveness. Acute and localized activation of GSDMD or GSDME may enhance immune-cell recruitment and tumor antigen exposure, whereas persistent pyroptotic signaling promotes fibrosis, angiogenesis, and immunosuppressive remodeling. This review examines the molecular circuitry linking pyroptosis with inflammasomes, metabolic stress, mitochondrial dysfunction, hypoxia, and epigenetic regulation in HCC. We further discuss how single-cell and spatial transcriptomic approaches reveal distinct pyroptotic immune niches associated with macrophage polarization, T-cell infiltration, and therapeutic response. Emerging therapeutic strategies including inflammasome modulation, gasdermin-targeted interventions, metabolic sensitization, and combination immunotherapy are also evaluated. Collectively, regulated pyroptosis may represent a promising immunomodulatory framework for improving precision therapy in HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: t.alramadneh@ammanu.edu.jo.
- Department of basic medical sciences, Termez University of Economics and Service, Termez, Uzbekistan.
- Department of Medical Radiology, Samarkand State Medical University, Samarkand, Uzbekistan.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India. Electronic address: h.malathi@jainuniversity.ac.in.
- Department of Pharmacy, College of Pharmacy, The Islamic University, Najaf, Iraq. Electronic address: Nadyh.Abdul.Alhady@iunajaf.edu.iq.
- Centre for Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India; Sharda School of Bio-Science&Technology, Sharda University, Greater Noida, India.
Zitieren
APA
AlRamadneh, T. N., Kholmurodov, I., Boboyeva, N., Hanumanthayya, M., Alhady, N. A., Singhal, D., Panigrahi, R., & Tailor, N. K. (2026). Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma. Clinical Immunology, 288, 110765. https://doi.org/10.1016/j.clim.2026.110765
Vancouver
AlRamadneh TN, Kholmurodov I, Boboyeva N, Hanumanthayya M, Alhady NA, Singhal D, et al. Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma. Clinical Immunology. 2026;288:110765. doi:10.1016/j.clim.2026.110765
BibTeX
@article{AlRamadneh2026,
author = {AlRamadneh, Tareq Nayef and Kholmurodov, Inoyatillo and Boboyeva, Naina and Hanumanthayya, Malathi and Alhady, Nadyh Abdul and Singhal, Divya and Panigrahi, Rajashree and Tailor, Navin Kumar},
title = {Gasdermin-mediated pyroptosis as a prognostic biomarker and therapeutic target in hepatocellular carcinoma},
journal = {Clinical Immunology},
year = {2026},
volume = {288},
pages = {110765},
doi = {10.1016/j.clim.2026.110765}
}
EUVIMED